CINEMARK HOLDINGS INC (CNK)

US17243V1026 - Common Stock

17.43  +0.29 (+1.69%)

After market: 17.44 +0.01 (+0.06%)

Fundamental Rating

5

Taking everything into account, CNK scores 5 out of 10 in our fundamental rating. CNK was compared to 76 industry peers in the Entertainment industry. Both the profitability and the financial health of CNK get a neutral evaluation. Nothing too spectacular is happening here. CNK has a correct valuation and a medium growth rate.



6

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
CNK had a positive operating cash flow in the past year.
In multiple years CNK reported negative net income over the last 5 years.
Of the past 5 years CNK 4 years had a positive operating cash flow.

1.2 Ratios

CNK has a better Return On Assets (3.81%) than 77.63% of its industry peers.
With an excellent Return On Equity value of 59.52%, CNK belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
CNK's Return On Invested Capital of 7.83% is amongst the best of the industry. CNK outperforms 82.89% of its industry peers.
Industry RankSector Rank
ROA 3.81%
ROE 59.52%
ROIC 7.83%
ROA(3y)-3.23%
ROA(5y)-3.49%
ROE(3y)-104.01%
ROE(5y)-75.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CNK has a Profit Margin of 6.01%. This is in the better half of the industry: CNK outperforms 76.32% of its industry peers.
In the last couple of years the Profit Margin of CNK has declined.
The Operating Margin of CNK (12.12%) is better than 80.26% of its industry peers.
In the last couple of years the Operating Margin of CNK has declined.
CNK has a better Gross Margin (64.55%) than 84.21% of its industry peers.
In the last couple of years the Gross Margin of CNK has remained more or less at the same level.
Industry RankSector Rank
OM 12.12%
PM (TTM) 6.01%
GM 64.55%
OM growth 3YN/A
OM growth 5Y-3.2%
PM growth 3YN/A
PM growth 5Y-1.8%
GM growth 3Y-0.58%
GM growth 5Y0.38%

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNK is still creating some value.
CNK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CNK has been increased compared to 5 years ago.
The debt/assets ratio for CNK has been reduced compared to a year ago.

2.2 Solvency

CNK has an Altman-Z score of 1.11. This is a bad value and indicates that CNK is not financially healthy and even has some risk of bankruptcy.
CNK has a Altman-Z score of 1.11. This is comparable to the rest of the industry: CNK outperforms 55.26% of its industry peers.
The Debt to FCF ratio of CNK is 8.44, which is on the high side as it means it would take CNK, 8.44 years of fcf income to pay off all of its debts.
CNK has a better Debt to FCF ratio (8.44) than 67.11% of its industry peers.
A Debt/Equity ratio of 7.96 is on the high side and indicates that CNK has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 7.96, CNK is doing worse than 77.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 7.96
Debt/FCF 8.44
Altman-Z 1.11
ROIC/WACC1.02
WACC7.67%

2.3 Liquidity

A Current Ratio of 1.45 indicates that CNK should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.45, CNK is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
CNK has a Quick Ratio of 1.42. This is a normal value and indicates that CNK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CNK (1.42) is better than 67.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.42

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 154.67% over the past year.
Measured over the past years, CNK shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.99% on average per year.
The Revenue has grown by 24.93% in the past year. This is a very strong growth!
Measured over the past years, CNK shows a decrease in Revenue. The Revenue has been decreasing by -0.98% on average per year.
EPS 1Y (TTM)154.67%
EPS 3YN/A
EPS 5Y-8.99%
EPS growth Q2Q81.71%
Revenue 1Y (TTM)24.93%
Revenue growth 3Y64.71%
Revenue growth 5Y-0.98%
Revenue growth Q2Q6.54%

3.2 Future

Based on estimates for the next years, CNK will show a small growth in Earnings Per Share. The EPS will grow by 0.65% on average per year.
The Revenue is expected to grow by 1.80% on average over the next years.
EPS Next Y-38.47%
EPS Next 2Y15.37%
EPS Next 3Y18.67%
EPS Next 5Y0.65%
Revenue Next Year-6.34%
Revenue Next 2Y3.1%
Revenue Next 3Y3.91%
Revenue Next 5Y1.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.17 indicates a correct valuation of CNK.
Compared to the rest of the industry, the Price/Earnings ratio of CNK indicates a rather cheap valuation: CNK is cheaper than 85.53% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 24.55, CNK is valued a bit cheaper.
A Price/Forward Earnings ratio of 23.03 indicates a rather expensive valuation of CNK.
Based on the Price/Forward Earnings ratio, CNK is valued cheaply inside the industry as 80.26% of the companies are valued more expensively.
CNK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.92.
Industry RankSector Rank
PE 14.17
Fwd PE 23.03

4.2 Price Multiples

81.58% of the companies in the same industry are more expensive than CNK, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CNK is valued cheaper than 96.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.19
EV/EBITDA 6.4

4.3 Compensation for Growth

CNK has a very decent profitability rating, which may justify a higher PE ratio.
CNK's earnings are expected to grow with 18.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.37%
EPS Next 3Y18.67%

0

5. Dividend

5.1 Amount

CNK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CINEMARK HOLDINGS INC

NYSE:CNK (5/1/2024, 7:04:00 PM)

After market: 17.44 +0.01 (+0.06%)

17.43

+0.29 (+1.69%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.12B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.17
Fwd PE 23.03
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.81%
ROE 59.52%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.12%
PM (TTM) 6.01%
GM 64.55%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 7.96
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.45
Quick Ratio 1.42
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)154.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-38.47%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)24.93%
Revenue growth 3Y64.71%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y